We are live on ! Find out more
CA

Continental Advisors Portfolio holdings

AUM $196M
1-Year Est. Return 24.19%
This Fund
S&P 500
This Quarter Est. Return
-3.71%
1 Year Est. Return
+24.19%
3 Year Est. Return
+67.62%
5 Year Est. Return
+60.86%
10 Year Est. Return
+208.23%
AUM
$228M
AUM Growth
-$19.8M
Cap. Flow
-$16.2M
Cap. Flow %
-7.1%
Top 10 Hldgs %
56.44%
Holding
47
New
2
Increased
13
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$2.81M
2
FHI icon
Federated Hermes
FHI
+$1.75M
3
CNNE icon
Cannae Holdings
CNNE
+$1.73M
4
TFC icon
Truist Financial
TFC
+$1.7M
5
RF icon
Regions Financial
RF
+$970K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.62M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.14M
3
GS icon
Goldman Sachs
GS
+$878K
4
PRGO icon
Perrigo
PRGO
+$852K
5
SHEL icon
Shell
SHEL
+$286K

Sector Composition

Rank Sector Weight
1 Financials 25.24%
2 Healthcare 16.2%
3 Technology 4.15%
4 Consumer Discretionary 1.9%
5 Materials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$939B
$3.06M 1.34%
15,135
– –
RF icon
27
Regions Financial
RF
$26.3B
$3.06M 1.34%
152,500
+50,000
+49% +$970K
B
28
Barrick Mining
B
$62.2B
$2.98M 1.31%
178,617
+12,500
+8% +$212K
BKD icon
29
Brookdale Senior Living
BKD
$3.62B
$2.75M 1.21%
402,244
-29,500
-7% -$200K
EWS icon
30
iShares MSCI Singapore ETF
EWS
$1.01B
$2.71M 1.19%
141,176
-15,000
-10% -$286K
SHEL icon
31
Shell
SHEL
$245B
$2.64M 1.16%
36,520
-4,000
-10% -$286K
XBI icon
32
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$2.61M 1.15%
28,200
+5,000
+22% +$448K
IEMG icon
33
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$2.18M 0.96%
40,800
– –
GS icon
34
Goldman Sachs
GS
$313B
$1.94M 0.85%
4,293
-2,000
-32% -$878K
CAH icon
35
Cardinal Health
CAH
$53.4B
$1.79M 0.79%
18,184
– –
SSB icon
36
SouthState Bank Corp
SSB
$10.4B
$1.41M 0.62%
18,512
– –
IBTX
37
DELISTED
Independent Bank Group, Inc.
IBTX
$810K 0.36%
17,785
– –
XRAY icon
38
Dentsply Sirona
XRAY
$2.59B
$772K 0.34%
+31,000
New +$889K
PROV icon
39
Provident Financial
PROV
$108M
$729K 0.32%
58,308
– –
IIIV icon
40
i3 Verticals
IIIV
$395M
$635K 0.28%
+28,769
New +$607K
FBNC icon
41
First Bancorp
FBNC
$2.6B
$464K 0.2%
14,531
– –
GDX icon
42
VanEck Gold Miners ETF
GDX
$23B
$427K 0.19%
12,573
– –
RVSB icon
43
Riverview Bancorp
RVSB
$107M
$396K 0.17%
99,209
– –
QQQ icon
44
PUT
Invesco QQQ Trust
QQQ
$455B
– –
-52,000
Closed -$23.1M
RF icon
45
CALL
Regions Financial
RF
$26.3B
– –
-40,000
Closed -$842K
TFC icon
46
CALL
Truist Financial
TFC
$63.2B
– –
-50,000
Closed -$1.95M
XBI icon
47
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
– –
-5,000
Closed -$474K
1
2

Similar funds

LWA
Legacy Wealth Advisors Miami, Florida $196M AUM
NWA
Navis Wealth Advisors Rye Brook, New York $196M AUM 33.05% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
PAM
Peninsula Asset Management Bradenton, Florida $196M AUM 10.62% 1-Year Est. Return
MAMF
Mirabaud Asset Management (France) Paris, France $196M AUM
CCP
Cyrus Capital Partners New York $196M AUM 123.68% 1-Year Est. Return
ACM
AUA Capital Management Camp Hill, Pennsylvania $196M AUM 18.71% 1-Year Est. Return
CPRPA
Cerity Partners Retirement Plan Advisors New York $196M AUM

Continental Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Continental Advisors held 47 positions worth $228M, down 8% from $248M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Continental Advisors withdrew a net $16.2M in Q2 2024, closing 4 positions and reducing 13 holdings. Its largest reduction was Pfizer, cutting an estimated $1.62M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Continental Advisors opened a new position in Dentsply Sirona worth $772K.

  • Continental Advisors's largest Q2 2024 buy was Dentsply Sirona: 31,000 shares worth $772K.
  • Continental Advisors added most to Viatris in Q2 2024, an estimated $2.81M increase.
  • Continental Advisors's biggest Q2 2024 reduction was Pfizer, cutting an estimated $1.62M.
  • Continental Advisors's ten largest holdings make up 56% of its $228M portfolio in Q2 2024.
  • Continental Advisors opened 2 new positions and closed 4 in Q2 2024.
  • Continental Advisors's portfolio value fell 8% quarter-over-quarter to $228M.

Based on Continental Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.